Co-Inhibition of BCL-W and BCL2 Restores Antiestrogen Sensitivity through BECN1 and Promotes an Autophagy-Associated Necrosis
Anatasha C. Crawford, Rebecca B. Riggins, Ayesha N. Shajahan et al. · 2010
Read Co-Inhibition of BCL-W and BCL2 Restores Antiestrogen Sensitivity through BECN1 and Promotes an Autophagy-Associated Necrosis by Anatasha C. Crawford, Rebecca B. Riggins, Ayesha N. Shajahan et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0008604.txt.
Description
Anatasha Crawford and co-authors study drug resistance in breast cancer in a 2010 PLOS ONE paper. BCL2 family members affect cell fate decisions in breast cancer. The role of BCL-W, also called BCL2L2, was unknown. Both BCL-W and BCL2 block apoptosis, the cell death program. Antiestrogen drugs such as fulvestrant treat hormone-sensitive breast cancers. The team test how these blockers affect response to that drug, using cell and tumor models.
Co-inhibition of BCL-W and BCL2 restores antiestrogen sensitivity. It does so through BECN1, a gene that drives autophagy. The treated cells die by an autophagy-associated necrosis. Blocking both survival proteins may rescue failing hormone therapy.
Catalog record
| CREATOR | Anatasha C. Crawford, Rebecca B. Riggins, Ayesha N. Shajahan et al. |
|---|---|
| YEAR | 2010 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 45 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0008604